GIGA-CRC In Vivo Imaging, Université de Liège, Liège, Belgium.
ORA Neptis, Philippeville, Belgium.
Sci Rep. 2022 Nov 4;12(1):18655. doi: 10.1038/s41598-022-23552-8.
N-succinimidyl-4-[F]fluorobenzoate ([F]SFB), a widely used labeling agent to introduce the 4-[F]fluorobenzoyl-prosthetic group, is normally obtained in three consecutive steps from [F]fluoride ion. Here, we describe an efficient one-step labeling procedure of [F]SFB starting from a tin precursor. This method circumvents volatile radioactive side-products and simplifies automatization. [F]SFB was obtained after HPLC purification in a yield of 42 + 4% and a radiochemical purity (RCP) > 99% (n = 6). In addition, we investigate the automation of the coupling of [F]SFB to a nanobody (cAbBcII10, targeting β-lactamase enzyme) and purification by size exclusion chromatography (PD-10 desalting column) to remove unconjugated reagent. Production and use of [F]SFB were implemented on a radiosynthesis unit (Neptis). The fully automated radiosynthesis process including purification and formulation required 160 min of synthesis time. [F]SFB-labeled nanobody was obtained in a yield of 21 + 2% (activity yield 12 + 1% non-decay corrected) and a radiochemical purity (RCP) of > 95% (n = 3). This approach simplifies [F]SFB synthesis to one-step, enhances the yield in comparison to the previous report and enables the production of radiolabeled nanobody on the same synthesis module.
N-琥珀酰亚胺基-4-[F]氟代苯甲酸酯 ([F]SFB),一种广泛用于引入 4-[F]氟苯甲酰基假基的标记试剂,通常需要经过三个连续的步骤从氟化物离子中获得。在这里,我们描述了一种从锡前体制备 [F]SFB 的高效一步标记程序。该方法避免了挥发性放射性副产物,并简化了自动化操作。[F]SFB 经 HPLC 纯化后,收率为 42±4%,放射化学纯度(RCP)>99%(n=6)。此外,我们还研究了 [F]SFB 与纳米抗体(cAbBcII10,针对β-内酰胺酶)的偶联自动化以及通过尺寸排阻色谱(PD-10 脱盐柱)的纯化,以去除未结合的试剂。[F]SFB 的生产和使用在放射合成单元(Neptis)上进行。包括纯化和制剂在内的全自动放射合成过程需要 160 分钟的合成时间。[F]SFB 标记的纳米抗体的产率为 21±2%(活性产率为 12±1%,未衰变校正),放射化学纯度(RCP)>95%(n=3)。这种方法将 [F]SFB 合成简化为一步,与之前的报告相比提高了产率,并能够在同一合成模块上生产放射性标记的纳米抗体。